Literature DB >> 9361105

Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman's disease in a schizophrenic patient.

H Katano1, K Kaneko, S Shimizu, T Saito, T Irié, S Mori.   

Abstract

Follicular dendritic cell (FDC) sarcoma is an exceedingly rare neoplasm of unknown pathogenesis. A case of FDC sarcoma complicated by the hyaline-vascular type Castleman's disease occurring in a schizophrenic male is presented. Swelling of the left cervical lymph node appeared in a 44-year-old male schizophrenic who had been medicated with major tranquilizers for 20 years. He had had a history of cervical lymphadenopathy 14 years before, for which a diagnosis of hyaline-vascular type Castleman's disease had been made. The present specimen, obtained from the same site, was an enlarged lymph node heavily infiltrated with oval to spindle-shaped atypical cells but was uninvolved at the periphery. The infiltrating cells showed nodular or sheet-like growth, occasionally taking fascicular or storiform patterns. Follicular involvement was also common. Peculiarly, various amounts of small lymphocytes were intermingled with the neoplastic cells. The atypical cells expressed two FDC-specific antigens, DRC-1 and Ki-M4 antigen, together with a few other markers that are shared by FDC, including CD21 and HLA-DR. These findings clearly show the tumor to be FDC sarcoma. In addition, a peculiar fibro-hyalinous change in the lymph follicle, which is compatible with hyaline-vascular type Castleman's disease, was noted at the periphery of the lymph node where neoplastic cells had not infiltrated. Surprisingly, similar hyaline-vascular changes were observed in the previous biopsy taken 14 years ago. Meanwhile, Kaposi's sarcoma-associated herpesvirus, which is often identified from generalized Castleman's disease, was not identified in the present case by polymerase chain reaction study. Thus, this case is unique in two aspects: (i) the overlap of FDC sarcoma with hyaline-vascular type follicular changes; and (ii) its occurrence in a schizophrenic patient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361105     DOI: 10.1111/j.1440-1827.1997.tb04445.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma.

Authors:  Lan Li; Yong-Hong Shi; Zhi-Juan Guo; Tian Qiu; Lei Guo; Hong-Ying Yang; Xun Zhang; Xin-Ming Zhao; Qin Su
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity.

Authors:  Jinru Shia; Wen Chen; Laura H Tang; Diane L Carlson; Jin Qin; Jose G Guillem; Jennifer Nobrega; W Douglas Wong; David S Klimstra
Journal:  Virchows Arch       Date:  2006-06-07       Impact factor: 4.064

Review 3.  Follicular dendritic cell sarcoma of parapharyngeal space: a case report and review of the literature.

Authors:  Turki Al-Hussain; Muhammad Saleem; Suresh Babu Velagapudi; Mohammad Anas Dababo
Journal:  Head Neck Pathol       Date:  2014-03-26

Review 4.  Follicular dendritic cell sarcoma of the head and neck: Case report, literature review, and pooled analysis of 97 cases.

Authors:  John Pang; Wojciech K Mydlarz; Zhen Gooi; Kevin M Waters; Justin Bishop; James J Sciubba; Young J Kim; Carole Fakhry
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

5.  Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.

Authors:  Shino Fujimoto; Tomoyuki Sakai; Hiroshi Kawabata; Nozomu Kurose; Sohsuke Yamada; Mariko Doai; Munetaka Matoba; Haruka Iwao-Kawanami; Takafumi Kawanami; Shuichi Mizuta; Toshihiro Fukushima; Hiroki Mizumaki; Masaki Yamaguchi; Yasufumi Masaki
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.